Follow the JCRファーマ株式会社 share price and the full management transaction log of the company, a publicly traded company based in Japan. Shares are quoted on JP JP, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, JCRファーマ株式会社 has logged 11 insider filings. Market capitalisation: €169.7bn. The latest transaction was filed on 20 February 2025 (Holding update). Among the most active insiders: Nomura Asset Management Co., Ltd.. Every trade is accessible without an account.
Analysts rate JCRファーマ株式会社 Buy (bullish), based on 6 analysts. Average price target: JP¥4,833.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
11 of 11 declarations
JCR Pharma, Inc. is a company specializing in the healthcare and pharmaceutical sector. It is listed on the XTKS market.